|Articles|April 1, 2008
- Applied Clinical Trials-04-01-2008
- Volume 0
- Issue 0
Global News
News tidbits from around the world
Advertisement
- A new policy adopted in the Gambia identifies Coartem, an artemisinin-based combination therapy, as the country's first-line treatment for uncomplicated malaria. Previously, chloroquine was the country's first-line treatment, but a rise in chloroquine resistance prompted the country to make the switch.
- For the first time in the European Commission's (EC) history, European drug company offices are now subject to surprise inspections, as the EC recently initiated an inquiry into the state of competition in the pharmaceutical sector. The EC hopes to uncover the reasons as to why there has been a decrease in novel medicines that make it to the market and why there is a holdup in generic market entry. The Commission will also attempt to determine whether certain agreements between pharma companies infringe upon restrictive business practice laws. Inquiry results are expected in the spring of 2009.
- International health research and bioethics experts and policy makers took part in a roundtable on the establishment of African health research guidelines at the UN Economic Commission for Africa and the African Union's Conference, Science with Africa, held in Ethiopia March 3–7. The discussion aimed to encourage the development of a foundation for legal and regulatory best practices in science and ethics in Africa, which could boost research and development in the country and help find cures for major diseases that affect a disproportionately high number of Africans as compared to the rest of the world.
Articles in this issue
about 18 years ago
Buenos DIAs from Barcelonaabout 18 years ago
Drug Pooling: Power and Pitfallsabout 18 years ago
A Pandora's Box for Clinical Trials?about 18 years ago
A Carrot and Sticks Approachabout 18 years ago
Research, Investigator Conduct Under Scrutinyabout 18 years ago
Marked Decline in Clinical Operations Productivityabout 18 years ago
Key Factors in CRO Selectionabout 18 years ago
Animating Informed Consentabout 18 years ago
EU Seeks Hematology Guidanceabout 18 years ago
The Local Central Lab ModelAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Why Real-World Evidence Can No Longer Wait Until After Approval
2
ACT Brief: AI-Driven Enrollment Results, Statistician Standards in Early Phase, and RNA Editing for Kidney Disease
3
SCOPE X: The COPD Case Study That Shows What AI Can Do for Enrollment
4
Three Tensions Transforming Clinical Operations Excellence
5